230 related articles for article (PubMed ID: 33719963)
1. Synthesis and Biological Evaluation of New 1,2,3-Triazole Derivatives of the Chrysin Flavonoid as Anticancer Agents.
Noole V; Krishna T; Godeshala S; Meraji S; Rege K; Reddy CK; Kedika B
Anticancer Agents Med Chem; 2022; 22(1):160-168. PubMed ID: 33719963
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and biologic evaluation of novel chrysin derivatives as cytotoxic agents and caspase-3/7 activators.
Al-Oudat BA; Alqudah MA; Audat SA; Al-Balas QA; El-Elimat T; Hassan MA; Frhat IN; Azaizeh MM
Drug Des Devel Ther; 2019; 13():423-433. PubMed ID: 30774307
[TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of novel 1,2,3-triazole-dithiocarbamate hybrids as potential anticancer agents.
Duan YC; Ma YC; Zhang E; Shi XJ; Wang MM; Ye XW; Liu HM
Eur J Med Chem; 2013 Apr; 62():11-9. PubMed ID: 23353743
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and Preclinical Evaluation of Indole Triazole Conjugates as Microtubule Targeting Agents that are Effective against MCF-7 Breast Cancer Cell Lines.
Yele V; Pindiprolu SKSS; Sana S; Ramamurty DSVNM; Madasi JRK; Vadlamani S
Anticancer Agents Med Chem; 2021; 21(8):1047-1055. PubMed ID: 32981511
[TBL] [Abstract][Full Text] [Related]
5. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of novel 1,2,3-triazole-pyrimidine hybrids as potential anticancer agents.
Ma LY; Pang LP; Wang B; Zhang M; Hu B; Xue DQ; Shao KP; Zhang BL; Liu Y; Zhang E; Liu HM
Eur J Med Chem; 2014 Oct; 86():368-80. PubMed ID: 25180925
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and molecular docking studies of thymol based 1,2,3-triazole hybrids as thymidylate synthase inhibitors and apoptosis inducers against breast cancer cells.
Alam MM; Malebari AM; Syed N; Neamatallah T; Almalki ASA; Elhenawy AA; Obaid RJ; Alsharif MA
Bioorg Med Chem; 2021 May; 38():116136. PubMed ID: 33894490
[TBL] [Abstract][Full Text] [Related]
8. Moxifloxacin-isatin Hybrids Tethered by 1,2,3-triazole and their Anticancer Activities.
Yang M; Liu H; Zhang Y; Wang X; Xu Z
Curr Top Med Chem; 2020; 20(16):1461-1467. PubMed ID: 31994464
[TBL] [Abstract][Full Text] [Related]
9. From triazolophthalazines to triazoloquinazolines: A bioisosterism-guided approach toward the identification of novel PCAF inhibitors with potential anticancer activity.
El-Shershaby MH; Ghiaty A; Bayoumi AH; Al-Karmalawy AA; Husseiny EM; El-Zoghbi MS; Abulkhair HS
Bioorg Med Chem; 2021 Jul; 42():116266. PubMed ID: 34126285
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of 3-amino-1,2,4-triazole derivatives as potential anticancer compounds.
Grytsai O; Valiashko O; Penco-Campillo M; Dufies M; Hagege A; Demange L; Martial S; Pagès G; Ronco C; Benhida R
Bioorg Chem; 2020 Nov; 104():104271. PubMed ID: 32992279
[TBL] [Abstract][Full Text] [Related]
11. Spirooxindole-derived morpholine-fused-1,2,3-triazoles: Design, synthesis, cytotoxicity and apoptosis inducing studies.
Senwar KR; Sharma P; Reddy TS; Jeengar MK; Nayak VL; Naidu VG; Kamal A; Shankaraiah N
Eur J Med Chem; 2015 Sep; 102():413-24. PubMed ID: 26301558
[TBL] [Abstract][Full Text] [Related]
12. Green synthesis and anticancer potential of chalcone linked-1,2,3-triazoles.
Yadav P; Lal K; Kumar A; Guru SK; Jaglan S; Bhushan S
Eur J Med Chem; 2017 Jan; 126():944-953. PubMed ID: 28011424
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of a novel class of ethacrynic acid derivatives containing triazoles as potent anticancer agents.
El Abbouchi A; El Brahmi N; Hiebel MA; Bignon J; Guillaumet G; Suzenet F; El Kazzouli S
Bioorg Chem; 2021 Oct; 115():105293. PubMed ID: 34426162
[TBL] [Abstract][Full Text] [Related]
14. New 1,2,4-triazole/pyrazole hybrids linked to oxime moiety as nitric oxide donor celecoxib analogs: Synthesis, cyclooxygenase inhibition anti-inflammatory, ulcerogenicity, anti-proliferative activities, apoptosis, molecular modeling and nitric oxide release studies.
Fadaly WAA; Elshaier YAMM; Hassanein EHM; Abdellatif KRA
Bioorg Chem; 2020 May; 98():103752. PubMed ID: 32197148
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and biological evaluation of novel 3-alkylsulfanyl-4-amino-1,2,4-triazole derivatives.
Zhao PL; Chen P; Li Q; Hu MJ; Diao PC; Pan ES; You WW
Bioorg Med Chem Lett; 2016 Aug; 26(15):3679-83. PubMed ID: 27287368
[TBL] [Abstract][Full Text] [Related]
16. Molecular docking studies, biological evaluation and synthesis of novel 3-mercapto-1,2,4-triazole derivatives.
Ghanaat J; Khalilzadeh MA; Zareyee D
Mol Divers; 2021 Feb; 25(1):223-232. PubMed ID: 32067134
[TBL] [Abstract][Full Text] [Related]
17. Bis-triazole-containing Compounds with Anticancer Potential: A Short Review.
Gao M; Diao Q; Gao F; Sun X; Xiao J
Curr Top Med Chem; 2021; 21(18):1674-1691. PubMed ID: 34323190
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and biological evaluation of chrysin benzimidazole derivatives as potential anticancer agents.
Wang Z; Deng X; Xiong S; Xiong R; Liu J; Zou L; Lei X; Cao X; Xie Z; Chen Y; Liu Y; Zheng X; Tang G
Nat Prod Res; 2018 Dec; 32(24):2900-2909. PubMed ID: 29063798
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and anticancer activities of novel 1,2,4-triazolo[3,4-a]phthalazine derivatives.
Xue DQ; Zhang XY; Wang CJ; Ma LY; Zhu N; He P; Shao KP; Chen PJ; Gu YF; Zhang XS; Wang CF; Ji CH; Zhang QR; Liu HM
Eur J Med Chem; 2014 Oct; 85():235-44. PubMed ID: 25086915
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of novel 1,2,3-triazole derivatives of coronopilin as anti-cancer compounds.
Khazir J; Hyder I; Gayatri JL; Prasad Yandrati L; Nalla N; Chasoo G; Mahajan A; Saxena AK; Alam MS; Qazi GN; Sampath Kumar HM
Eur J Med Chem; 2014 Jul; 82():255-62. PubMed ID: 24910974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
